🇺🇸 FDA
Patent

US 10774141

Antibody for binding to interleukin 4 receptor

granted A61KA61K38/00A61K39/395

Quick answer

US patent 10774141 (Antibody for binding to interleukin 4 receptor) held by SuZhou Connect Biopharmaceuticals, Inc. expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SuZhou Connect Biopharmaceuticals, Inc.
Grant date
Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K38/00, A61K39/395, A61K45/06, A61P